A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions
Author(s) -
L.C. Steffes,
Alexis A. Froistad,
Adam Andruska,
Mario Boehm,
Madeleine McGlynn,
Fan Zhang,
Wenming Zhang,
David Hou,
Xuefei Tian,
Lucile Miquerol,
Kari C. Nadeau,
Ross J. Metzger,
Edda Spiekerkoetter,
Maya E. Kumar
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.120.045750
Subject(s) - medicine , vascular smooth muscle , occlusive , pulmonary vasculature , vascular disease , cardiology , anatomy , pathology , smooth muscle , pulmonary artery
Pulmonary arterial hypertension (PAH) is a fatal disease characterized by profound vascular remodeling in which pulmonary arteries narrow because of medial thickening and occlusion by neointimal lesions, resulting in elevated pulmonary vascular resistance and right heart failure. Therapies targeting the neointima would represent a significant advance in PAH treatment; however, our understanding of the cellular events driving neointima formation, and the molecular pathways that control them, remains limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom